[1] Zhang P.The impact of population age structure, household savings rate and balance sheet on the banking system in China[J]. Journal of Jilin Financial Research(吉林金融研究), 2008, 11(1): 6-9. [2] O'Mahony D, O'Sullivan D, Byrne S, et al. STOPP /START criteria for potentially inappropriate prescribing in older people: version 2[J]. Age Ageing, 2015, 44(2): 213-218. [3] Samuel MJ.American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults[J]. J Am Geriatr Soc, 2015, 63(11):2227-2246. [4] Chen ZY, Liu LG, Tu DH, et al.Assessment of potentially inappropriate medication in community-dwelling elderly patients based on three criteria[J]. Chinese Journal of New Drugs and Clinical Remedies(中国新药与临床杂志), 2018, 37(12): 700-706. [5] Zhang XL, Wang YQ, Yan Y, et al.Development of primary standard of potentially inappropriate medication in Chinese aged people under morbid state[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2014, 16(2): 79-85. [6] Yan Y, Wang YQ, Shen Q, et al.Development of a list of potentially inappropriate medication for the Chinese aged people[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2015, 17(1): 19-26. [7] Rational Drug Use Branch of Chinese Association of Geriatric Research. Criteria of potentially inappropriate medications for older adults in China[J]. Adverse Drug Reactions Journal(药物不良反应杂志)), 2018, 20(1): 2-8. [8] Yuan LP, Wei JY, Wan LY, et al.Survey of potentially inappropriate medications of elderly inpatients in a pneumology department[J]. Chinese Journal of New Drugs(中国新药杂志), 2019, 28(24): 3042-3045. [9] He L.Analysis of irrational drug use in elderly inpatients[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药杂志), 2019, 12(12): 101-102. [10] Zeng JJ, Su YF, Weng YY.Analysis of potential inappropriate medication for elderly patients in the outpatient and emergency department of our hospital[J]. Chinese Journal of Rural Medicine and Pharmacy(中国乡村医药), 2019, 26(21): 31-33. [11] Yang QY, Liu X, Pan Q, et al.Medication risk and safety evaluation for elderly patients in the nursing community by 2019 Beers criteria[J]. World Clinical Drugs(世界临床药物), 2019, 40(9): 664-670. [12] Gu P, Li ZY, Mi JL, et al.Analysis of potentially inappropriate medication and risk factors in older inpatients[J]. Pharmaceutical Care and Research(药学服务与研究), 2019, 19(5): 345-348. [13] Liu YL, Sun Y, Fang X, et al.Analysis of potentially inappropriate medications in 317 elderly inpatients[J]. China Pharmaceuticals(中国药业), 2019, 28(19): 85-89. [14] Wang P, Cui YJ, Zhai XL, et al.Relationship between potentially inappropriate medications and physical function in hospitalized elderly patients[J]. Practical Geriatrics(实用老年医学), 2019(9): 912-916. [15] Ruan SF, Wu XL.Analysis of irrational drug use in elderly inpatients based on the criteria of potentially inappropriate medications for older adults in China[J]. Pharmacy Today(今日药学), 2019, 29(4): 263-266. [16] Yin YM.Comparison of the effects of clopidogrel and aspirin for elderly patients with coronary heart disease[J]. Contemporary Medical Symposium(当代医药论丛), 2018, 16(23): 111-113. [17] Xu XJ, Liu S, Liu YY, et al.Efficacy of clopidogrel in elderly patients with transient ischemic attack and disturbance of consciousness[J]. Journal of Preventive Medicine of Chinese People's Liberation Army(解放军预防医学杂志), 2019, 37(1): 46-48. [18] Gao Y.Observation of the effect of clopidogrel combined with aspirin in the treatment of elderly transient ischemic attack[J]. Cardiovascular Disease Electronic Journal of Integrated Traditional Chinese and Western Medicine(中西医结合心血管病杂志), 2018, 6(35): 58-58. [19] Li M, Zhou LJ, Zhan F, et al.Based on CYP2C19 genotype of clopidogrel and ticagrelor treatment of acute coronary syndromes individualized drug analysis[J]. Chinese Pharmaceutical Journal(中国药学杂志), 2019, 54(9): 753-760. [20] Sleep Disorder Group, Neurology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of insomnia in Chinese adults[J]. Chinese Journal of Neurology(中华神经科杂志), 2018, 51(5): 324-335. [21] Li A, Zhang B.Survey and consideration on safety status of traditional Chinese medicine application in 685 primary healthcare workers[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(12): 721-727. [22] Endocrinology and Metabolism Branch of Chinese Association of Geriatric Research. Expert consensus on risk management of polypharmacy in elderly[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(10): 627-640. |